News & Events
Explore our latest news, insights, and events.
DeepHealth Expands Breast Suite with New FDA-Cleared AI Capabilities
DeepHealth has received FDA 510(k) clearances for Breast Arterial Calcification Assessment and prior exam integration into ProFound Pro. BAC Assessment is a tool applied to standard screening mammograms that automatically identifies breast arterial calcifications, a potential early indicator of cardiovascular disease.1 ProFound Pro with prior exam integration enables the comparison of breast tissue over time amongst prior and current exams, and will be brought to market as Mammo Dx.2
DeepHealth Achieves Multiple Regulatory Milestones for Neuro, Prostate and LumbarMR
DeepHealth has received CE Marking for the Brain Health and Brain Age solutions within its Neuro Suite, CE Marking for its LumbarMR solution, and FDA 510(k) clearance and CE Marking for the Prostate AI solution within its Prostate Suite.